Evidence map›Paper›PMID 31018956›Full record

ArticleCancer immunology research2019

IL1R8 Deficiency Drives Autoimmunity-Associated Lymphoma Development.

Federica Riva, Maurilio Ponzoni, Domenico Supino, Maria Teresa Sabrina Bertilaccio, Nadia Polentarutti, Matteo Massara, Fabio Pasqualini, Roberta Carriero, Anna Innocenzi, Achille Anselmo and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer immunology research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 40 citations in OpenAlex.

  1. IL-1 family cytokines in inflammation and immunity.Cellular & molecular immunology · 2025
    Review
  2. Review
  3. SIGIRR: An Orphan Receptor Mediating Anti-inflammatory Actions.Expert reviews in molecular medicine · 2025
    Review
  4. Article
  5. Article
  6. Veterinary sciences · 2022
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

Federica RivaDepartment of Veterinary Medicine, University of Milan, Milan, Italy.
Maurilio PonzoniAteneo Vita-Salute and Unit of Lymphoid Malignancies, IRCCS San Raffaele Scientific Institute; Pathology Unit, San Raffaele Scientific Institute, Milano, Italy.
Domenico SupinoHumanitas Research Hospital, Rozzano, Italy.
Maria Teresa Sabrina BertilaccioDivision of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
Nadia PolentaruttiHumanitas Research Hospital, Rozzano, Italy.
Matteo MassaraHumanitas Research Hospital, Rozzano, Italy.ORCID 0000-0001-6724-5633
Fabio PasqualiniHumanitas Research Hospital, Rozzano, Italy.
Roberta CarrieroHumanitas Research Hospital, Rozzano, Italy.
Anna InnocenziAteneo Vita-Salute and Unit of Lymphoid Malignancies, IRCCS San Raffaele Scientific Institute; Pathology Unit, San Raffaele Scientific Institute, Milano, Italy.
Achille AnselmoHumanitas Research Hospital, Rozzano, Italy.
Tania Veliz-RodriguezDivision of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
Giorgia SimonettiDivision of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
Hans-Joachim AndersMedizinische Klinik and Poliklinik IV, Klinikum der Universität München, LMU München, Germany.
Federico Caligaris-CappioDivision of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
Alberto MantovaniHumanitas Research Hospital, Rozzano, Italy.ORCID 0000-0001-5578-236X
Marta MuzioDivision of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milano, Italy. cecilia.garlanda@humanitasresearch.it marta.muzio@hsr.it.
Cecilia GarlandaHumanitas Research Hospital, Rozzano, Italy. cecilia.garlanda@humanitasresearch.it marta.muzio@hsr.it.
Vita-Salute San Raffaele University · ITIRCCS Humanitas Research Hospital · ITHumanitas University · ITLMU Klinikum · DEUniversity of Milan · IT

Funding

European Research Council 669415
6 · The paper itself

Abstract

Chronic inflammation, including that driven by autoimmunity, is associated with the development of B-cell lymphomas. IL1R8 is a regulatory receptor belonging to the IL1R family, which negatively regulates NF-κB activation following stimulation of IL1R or Toll-like receptor family members. IL1R8 deficiency is associated with the development of severe autoimmune lupus-like disease in

Indexed as

Disease SusceptibilityAnimalsAutoimmunityBiomarkersCell Transformation, NeoplasticDisease Models, AnimalGene ExpressionGenetic Predisposition to DiseaseHumansImmunoglobulin Heavy ChainsImmunohistochemistryLymphomaLymphoma, Large B-Cell, DiffuseMiceNF-kappa BReceptors, Interleukin-1BiomarkersImmunoglobulin Heavy ChainsNF-kappa BReceptors, Interleukin-1SIGIRR protein, humanToll-Like Receptors

Identifiers

PMID31018956
PMCPMC7176492
OpenAlexW2940639839

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.